Nilotinib 150mg Capsules

Nilotinib 150mg is a BCR-ABL tyrosine-kinase inhibitor used for Philadelphia chromosome-positive chronic myeloid leukaemia. Molecular response and previous treatment help determine the regimen.
Take the scheduled doses approximately 12 hours apart. Have no food for at least 2 hours before and 1 hour after each dose. Swallow the capsules with water and avoid grapefruit.
Nilotinib inhibits BCR-ABL kinase activity, reducing the abnormal growth signal responsible for Ph-positive leukaemia-cell proliferation.
Rash, itching, nausea, headache and low blood counts may occur. QT prolongation, arterial vascular events and pancreatitis are important risks.
ECG, potassium, magnesium, glucose and lipid monitoring may be needed. Low electrolytes and medicines that prolong QT can increase arrhythmia risk.
Can reduce the molecular leukaemia burden and help maintain long-term disease control.
Food can markedly increase nilotinib exposure and contribute to cardiac toxicity.
It detects changes in cardiac repolarisation that may not cause early symptoms.
No. Treatment-free remission is considered only with defined eligibility and intensive molecular follow-up.
Skip it and take the next scheduled dose at the usual time. Do not take two doses together.
Philadelphia chromosome: a chromosome change producing BCR-ABL. QT interval: an ECG measure of cardiac electrical recovery. Molecular remission: very low disease levels measured by genetic testing.; AR: Nilotinib 150mg كبسولات; FR: Nilotinib 150mg gélules; PT: Nilotinib 150mg cápsulas; ES: Nilotinib 150mg cápsulas; RU: Nilotinib 150mg капсулы; ID: Nilotinib 150mg kapsul; VI: Nilotinib 150mg viên nang; MS: Nilotinib 150mg kapsul; TL: Nilotinib 150mg mga kapsula; ZH-SG: Nilotinib 150mg 胶囊
International B2B Enquiry
Send a structured B2B enquiry for Nilotinib 150mg Capsules under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Nilotinib 150mg Capsules